stockrow
Saturday 7 November 2026
Export ENLV’s income statement to Excel — free account
Enlivex Ltd.
ENLV Healthcare Biotechnology
- EPS
- +5,349.9%
- Free cash flow
- +35.9%
Quarter to June 2026, against a year earlier
1.27
0.00
0.00%
Follow ENLV
Alert me
| Jun '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
119.39 | 193.24 | 6.43 | 6.41 |
+8 more quarters Free account |
Net Debt/EBITDA |
881.46 | 300.51 | 7.35 | 6.52 | |
Debt/Assets |
0.35% | 0.02% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.89 | 0.64 | |
Capex/Depreciation |
— | (0.11) | (0.26) | (0.08) | |
Interest Coverage |
(3.12) | — | — | 2.54 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
0.00 | (13.83) | (19.85) | (12.12) | |
Cash per Share |
3,625.06 | 9,127.65 | 181.67 | 196.25 | |
Shareholders Equity per Share |
3,770.79 | 10,157.21 | 174.46 | 191.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3,770.79 | 10,157.21 | 174.46 | 191.69 | |
Free Cash Flow |
— | (2.63) | (1.99) | (1.20) | |
Working Capital |
3,719.58 | 1,734.16 | 16.47 | 18.00 | |
Capital Expenditures |
— | (0.01) | (0.02) | (0.01) | |
Net Current Asset Value |
2,749.28 | 1,351.13 | 16.04 | 17.78 | |
| Other line items | |||||
Quick Ratio |
119.28 | 192.75 | 6.01 | 5.86 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | (13.78) | (19.64) | (12.05) | |
Capex per Share |
0.00 | (0.04) | (0.21) | (0.07) | |
Average Payables |
1.11 | 2.31 | 0.23 | 0.42 | |
Average Assets |
2,462.00 | 1,177.34 | 25.37 | 27.25 | |
Average Common Equity |
1,959.43 | 979.27 | 22.03 | 23.81 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026